Francis Pospisil
Surgical · Grapevine, TXNPI 1134252620
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.5% of the total across 113 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 12.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $989 and has fallen 70.5% since, to $291 in 2025.
Across 113 payments — averaging $19.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$275
- Astellas Pharma US Inc$216
- Clarus Therapeutics Inc.$197
- Antares Pharma, Inc.$185
- Myovant Sciences Inc.$171
- Endo Pharmaceuticals Inc.$165
- plus $999 from 25 others
What the payments were for
- Food & beverage$2,15498%
- Education$552%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$2,209 in reported general payments places this provider in the 85th percentile of 804 surgical providers in Texas.
Other surgical in Grapevine
- Courtney DunavantAustin$389K
- Krista GranthamSan Antonio$187K
- Gerald BuchertBellaire$148K
- Gilberto SaenzGeorgetown$70K
- Andrea McNielHumble$48K
- Marilyn ShookHouston$46K
- Henry KinnebrewAustin$40K
- Josephine KarlDallas$18K
- Sarah IragorriAustin$18K
- Lonnie GinnDallas$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.